Novaliq GmbH Announces Licensing Agreement with AFT Pharmaceuticals
Novaliq, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced…
Read More...
Read More...